Research

Energy balance

Sustained weight loss of at least 5% achieved through pharmacotherapy or bariatric surgery is associated with a reduced risk of obesity-related cancers.

To reduce cancer risk, weight loss must be sustained over the long term. Losing at least 5% of body weight and keeping it off is associated with lower cancer risk. For those who struggle to maintain weight loss, pharmacotherapy or bariatric surgery can help sustain the loss, thereby preserving the cancer-protective benefits.

GoodSupportsHIGH confidence
Both maximum and sustained weight loss are essential for all forms of effective metabolic improvement, including cancer risk reduction.
Edward R. Sauter et al. · Cancers · 2024

Why this rating

Supported by long-term observational studies (Iowa Women's Health, WHI) and bariatric surgery data.

Source

Mechanisms by Which Pharmacotherapy May Impact Cancer Risk among Individuals with Overweight and Obesity

Edward R. Sauter et al. · Cancers · 2024

DOI 10.3390/cancers16193275

narrative_reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →